Catalog No.
YMD59001
Expression system
E. coli
Species
Mus musculus (Mouse)
Protein length
Leu28-Gly251
Predicted molecular weight
28.25 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q63912
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Oligodendrocyte-myelin glycoprotein, Omg, Omgp
Transport and expression of transporters for 3-O-methyl-D-glucose and L-methionine along the intestine of broiler chickens receiving different methionine supplements., PMID:40228340
Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases., PMID:39872535
[Successful treatment of rheumatoid arthritis complicated with myasthenia gravis with low-dose rituximab: A case report]., PMID:39690779
Ocular Myasthenia gravis: determining the predictive factors of secondary generalisation., PMID:39621280
Tocilizumab for the management of corticosteroid-resistant GO combined with OMG: a case series., PMID:39592974
Use of mendelian randomization to assess the causal associations of circulating plasma proteins with 12-lead ECG parameters., PMID:39486179
Plasma proteome-wide analysis of cerebral small vessel disease identifies novel biomarkers and disease pathways., PMID:39417098
Analysis of clinical features and outcomes in patients with ocular myasthenia gravis according to anti-acetylcholine receptor antibody-seropositivity., PMID:39356387
Sero-Positive Isolated Ocular Myasthenia Gravis., PMID:39280472
Clinical characteristics and therapeutic effect of myasthenia gravis coexisting with thyroid eye disease., PMID:39196497
Ocular versus generalized myasthenia gravis: a continuum associated with acetylcholine receptor antibody titers., PMID:39190980
A genome-wide association study of alloimmunization in the TOPMed OMG-SCD cohort identifies a locus on chromosome 12., PMID:38966903
Clinical features of double seronegative ocular myasthenia gravis., PMID:38416235
Ovarian Morphology in Girls Longitudinal Cohort Study: Pilot Evaluation of Ovarian Morphology as a Biomarker of Reproductive and Metabolic Features during the First Gynecological Year., PMID:38395192
Nontargeted Plasma Proteomic Analysis of Renal Disease and Pulmonary Hypertension in Patients with Sickle Cell Disease., PMID:38353026
Serum amyloid A facilitates expansion of CD4+ T cell and CD19+ B cell subsets implicated in the severity of myasthenia gravis patients., PMID:38214332
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study., PMID:38205656
Macrophage migration inhibitory factor: A noval biomarker upregulates in myasthenia gravis and correlates with disease severity and relapse., PMID:38159470
Two new bibenzyl methylglucosides as SIRT3 activators obtained through microbial transformation., PMID:38078645
Study of serum exosome miRNA as a biomarker for early onset adult ouclar myastthenia gravis., PMID:38013129
[A case of anti-acetylcholine receptor antibody-positive ocular myasthenia gravis with anti-titin antibody and anti-Kv1.4 antibody positive inflammatory myopathy]., PMID:37989286
Development and Validation of the American Heart Association's PREVENT Equations., PMID:37947085
Eicosanoid-Regulated Myeloid ENaC and Isolevuglandin Formation in Human Salt-Sensitive Hypertension., PMID:37675576
Clinical Characteristics Associated With Secondary Generalization in Patients With Ocular Myasthenia Gravis: A Systematic Review and Meta-analysis., PMID:37643888
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study., PMID:37009731
Quantitative determination of SLC2A1 variant functional effects in GLUT1 deficiency syndrome., PMID:37000947
Clinical characteristics, treatment and outcome of nivolumab-induced myasthenia gravis., PMID:36988830
Associations of Urine Biomarkers of Kidney Tubule Health With Incident Hypertension and Longitudinal Blood Pressure Change in Middle-Aged Adults: The CARDIA Study., PMID:36987923
Age of onset and factors affecting treatment responses in ocular myasthenia gravis., PMID:36879110
Ocular Myasthenia Gravis: A Current Overview., PMID:36778719
Ophthalmologic clinical features of ocular myasthenia gravis., PMID:36637960
BPIFA1 is a secreted biomarker of differentiating human airway epithelium., PMID:36519134
Prognostic predictors of remission in ocular myasthenia gravis., PMID:36474006
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study., PMID:36416136
Generalization of ocular myasthenia gravis 10 years after onset., PMID:36001142
Expression of TRAF6 in peripheral blood B cells of patients with myasthenia gravis., PMID:35978310
Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis., PMID:35874731
Consumption of oil macerated with garlic produces renovascular protective effects in adult apolipoprotein E-deficient mice., PMID:35797719
[Acupuncture combined with western medication for ocular myasthenia gravis: a randomized controlled trial]., PMID:35793884
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas., PMID:35474089
Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids., PMID:35458559
Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes., PMID:35246057
Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues., PMID:35163201
Differences in immunophenotypes between myasthenia gravis patients with and without thyroid antibodies., PMID:35147983
A Kalirin missense mutation enhances dendritic RhoA signaling and leads to regression of cortical dendritic arbors across development., PMID:34848542
Serum irisin levels in patients with myasthenia gravis., PMID:34709479
Myelin-associated proteins are potential diagnostic markers in patients with primary brain tumour., PMID:34601991
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race., PMID:34554658
Omarigliptin Prevents TNF-α-Induced Cellular Senescence in Rat Aorta Vascular Smooth Muscle Cells., PMID:34382399
GDNF requires HIF-1α and RET activation for suppression of programmed cell death of enteric neurons by metabolic challenge., PMID:34273501
For research use only. Not for human or drug use.
